期刊文献+

肿瘤体积和放疗剂量对局部晚期非小细胞肺癌预后的影响分析 被引量:2

Analysis the Gross Tumor Volume and Radiotherapy Dose Prognostic Impact for Locally Advance Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的:观察并探讨肿瘤体积和放疗剂量对局部晚期非小细胞肺癌预后的影响。方法选择2014年4月~2015年5月本院收治的90例局部晚期非小细胞肺癌患者为研究对象,根据CT扫描系统以及三维适形放射治疗的计划系统制作相应的3个靶区,分别命名为GTV-N、GTV-P以及GTV-T,研究并分析每个靶区里肿瘤体积和放疗剂量对局部晚期非小细胞肺癌预后的影响。结果 GTV-T小于100.00 cm^3患者的生存率高于GTV-T大于100.00 cm^3患者,P<0.05,差异具有统计学的意义。结论运用CT扫描系统以及三维适形放射治疗的计划系统治疗局部晚期非小细胞肺癌时,适当增加放疗的剂量有利于预后。 Objective Observation and explore the effect of tumor volume and radiotherapy dose on the prognosis of locally advanced non-small cell lung cancer. Methods Selected 90 cases with locally advanced non-small cell lung cancer from April 2014 to May 2015 as the object, according to the CT scanning system and three-dimensional conformal radiation therapy planning system making three corresponding target area, named for. And GTV-P and GTV-T, research and analyed of each target district tumor volume and dose of radiotherapy for locally advanced non influence the prognosis of small cell lung cancer. Results The survival rate of patients with GTV-T less than 100 GTV-T was higher than that of patients with cm^3 greater than 100 cm^3, P〈0.05, had difference statistically signiifcance. Conclusion Use CT scanning system and three-dimensional conformal radiation treatment planning system in treatment of locally advanced non small cell lung cancer, appropriate increase in radiation dose is conducive to the patient's prognosis.
作者 王红亚
出处 《中国继续医学教育》 2015年第19期82-83,共2页 China Continuing Medical Education
关键词 肿瘤体积 放疗剂量 非小细胞癌 预后 Tumor volume Radiotherapy dose Non small cell carcinoma Prognosis
  • 相关文献

参考文献6

二级参考文献51

  • 1金和坤,罗荣喜.诱导化疗加同步放化疗与单纯同步放化疗治疗局部晚期非小细胞肺癌的临床疗效比较[J].中外医疗,2008,27(16):44-45. 被引量:6
  • 2吕纪马,王绿化,周宗玫,张红星,陈东福.放射治疗同步紫杉醇化疗局部晚期非小细胞肺癌的Ⅱ期临床研究[J].中华放射肿瘤学杂志,2004,13(2):89-92. 被引量:68
  • 3王颖杰,王绿化,王鑫,冯勤付,张红星,肖泽芬,殷蔚伯.91例非小细胞肺癌三维适形放疗的临床分析[J].中华放射肿瘤学杂志,2005,14(4):241-244. 被引量:48
  • 4杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 5Hansen O, Paarup H, Sorensen P, et al. Curative radiotherapy of local advanced non-small-cell lung cancer: eight years of experience from odense. Ugeskr Laeger, 2005, 167:3497-3502.
  • 6Furuse K, Fukuoka M, Kawahara M, et al. Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage Ⅲ non-small-cell lung cancer. J Clin Oncol, 1999, 17:2692-2699.
  • 7Founel P, Robinet G, Thomas P, et al. A randomized phase Ⅲ trial of sequential chemo-radiotherapy versus concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer ( GLOT GFPC NPC 95-01 study). J Clin Oncol, 2005, 23: 5910-5917.
  • 8Ramalingam S, Pawlish K, Gadgeel S, et al. Lung cancer in young patients: analysis of a surveillance, epidemiology, and end results database. J Clin Oncol, 1998, 16:651-657.
  • 9Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst, 1980, 65: 25-32.
  • 10Wemer-Wasik M, Scott C, Cox JD, et al. Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys, 2000, 48 : 1475-1482.

共引文献35

同被引文献13

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部